Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 10, 2020 07:30 ET | Source: BetterLife Pharma

Pre-IND Discussion with U.S. FDA Helps BetterLife Set Up AP-003 Clinical Trials in Australia

VANCOUVER, Nov. 10, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company focused on development and...
November 04, 2020 08:00 ET | Source: BetterLife Pharma

BetterLife Pharma Signs eTMF Partner to Help Accelerate AP-003 Clinical Trial Operations

VANCOUVER, Nov. 04, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company that is beginning clinical...
October 28, 2020 08:00 ET | Source: BetterLife Pharma

BetterLife Provides Important Update on its Australian Clinical Study Design

Vancouver, Oct. 28, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company preparing human clinical trials of AP-003, its interferon alpha 2b...
October 28, 2020 05:00 ET | Source: BetterLife Pharma

UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon Beta

NEW YORK CITY, Oct. 28, 2020 (GLOBE NEWSWIRE) -- UPDATE: BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Synairgen PLC’s Interferon Beta The Chief...
October 27, 2020 07:30 ET | Source: BetterLife Pharma

BetterLife CEO Highlights Crucial Difference Between the Company’s Interferon Alpha 2b and Other Treatements

New York City, Oct. 27, 2020 (GLOBE NEWSWIRE) -- The Chief Executive Officer for BetterLife Pharma Inc. (OTCQB:BETRF) (CSE:BETR), an emerging biotechnology company currently preparing for clinical...
October 19, 2020 08:00 ET | Source: BetterLife Pharma

BETTERLIFE PHARMA ANNOUNCES UP TO $5.0 MILLION PRIVATE PLACEMENT OFFERING OF SPECIAL WARRANTS

VANCOUVER, Oct. 19, 2020 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART,...
October 15, 2020 08:00 ET | Source: BetterLife Pharma

BetterLife Names CRO for COVID-19 Clinical Trial in Australia

VANCOUVER, Oct. 15, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that it...
October 08, 2020 08:00 ET | Source: BetterLife Pharma

BetterLife Announces VirTrial as Clinical Trial Patient Monitoring Partner

VANCOUVER, Oct. 08, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that it...
September 30, 2020 07:30 ET | Source: BetterLife Pharma

BetterLife Receives FINRA Approval and Resumes Trading on the OTC Markets

VANCOUVER, Sept. 30, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, is pleased to announce that,...
September 23, 2020 07:30 ET | Source: BetterLife Pharma

BetterLife Provides Update on OTC Trading Activity

VANCOUVER, Sept. 23, 2020 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB: BETRF / FRA: NPAT) an emerging biotech company, today announced that it has...